灵康药业: 关于“灵康转债”2025年跟踪评级结果的公告

Core Viewpoint - The company, Lingkang Pharmaceutical Group Co., Ltd., has maintained its credit rating for both the company and its convertible bonds, indicating stable financial health and outlook [1][2]. Summary by Relevant Sections Company Credit Rating - The company's credit rating remains at "A-" with a stable outlook, consistent with the previous rating [1][2]. - The last rating was conducted by Dongfang Jincheng International Credit Assessment Co., Ltd. on June 18, 2024 [1]. Convertible Bond Rating - The credit rating for the "Lingkang Convertible Bonds" is also maintained at "A-" with a stable outlook, showing no change from the previous assessment [2].